Ken Galbraith
Chief Executive Officer chez ZYMEWORKS INC.
Fortune : 249 976 $ au 31/03/2024
Provenance du réseau au premier degré de Ken Galbraith
Entité | Type d'entité | Industrie | |
---|---|---|---|
University of British Columbia
353
| College/University | Other Consumer Services | 353 |
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada.
39
| Subsidiary | Biotechnology | 39 |
Syncona Partners LLP
Syncona Partners LLP Investment ManagersFinance Syncona Partners LLP (Syncona Partners) is a venture capital subsidiary of Syncona Investment Management Ltd. founded in 2012 by Martin Murphy. The firm is headquartered in London, United Kingdom.
27
| Subsidiary | Investment Managers | 27 |
Public Company | Pharmaceuticals: Major | 27 | |
Public Company | Pharmaceuticals: Major | 27 | |
QLT, Inc.
QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.
22
| Extinct | Miscellaneous Commercial Services | 22 |
Public Company | Biotechnology | 21 | |
Public Company | Pharmaceuticals: Major | 17 | |
Public Company | Medical Specialties | 16 | |
AnorMED, Inc.
AnorMED, Inc. Pharmaceuticals: MajorHealth Technology AnorMED is a chemistry-based biopharmaceutical company focused on the discovery, development and commercialization of new therapeutic products in the areas of hematology, HIV and oncology. The Company has four products in clinical development and a research program focused on a novel class of compounds that target specific chemokine receptors known to be involved in a variety of diseases.
10
| Extinct | Pharmaceuticals: Major | 10 |
AudienceView Ticketing Corp.
AudienceView Ticketing Corp. Packaged SoftwareTechnology Services AudienceView Ticketing Corp. engages in the provision and development of software and media solutions for ticket sales. It offers services through its platform, which under the brands of OvationTix, Vendini, TheaterMania, WhatsOnStage, LaughStub, ElectroStub, and TuneStub. The company was founded by Kevin Kimsa and Paul J. Atkinson in 2002 and is headquartered in Toronto, Canada.
9
| Holding Company | Packaged Software | 9 |
Liminal BioSciences Ltd.
Liminal BioSciences Ltd. BiotechnologyHealth Technology Part of Liminal R & D BioSciences, Inc., Liminal BioSciences Ltd. is a British biopharmaceutical company founded in 2015. The private company is based in Comberton, UK. The company is focused on the discovery and development of novel, small molecule drug candidates.
8
| Subsidiary | Biotechnology | 8 |
Genesys Capital Partners, Inc.
Genesys Capital Partners, Inc. Investment ManagersFinance Genesys Capital Partners Inc (Genesys Capital) is an independent venture capital firm founded in 2000 by Damian Lamb, Plumley and Kelly Holman. The firm is headquartered in Toronto.
8
| Private Company | Investment Managers | 8 |
Mutual Fd-Closed End | Investment Trusts/Mutual Funds | 5 | |
Kalium Health Ltd.
Kalium Health Ltd. Medical SpecialtiesHealth Technology Kalium Health Ltd. engages in the provision of clinical, technological, and healthcare services. It provides personalized electrolyte monitoring. The company was founded by Fiona Karet and Tom Collings and is headquartered in Cambridge, the United Kingdom.
2
| Holding Company | Medical Specialties | 2 |
Vancouver Aquarium
Vancouver Aquarium Miscellaneous Commercial ServicesCommercial Services Part of Herschend Family Entertainment Corp., Vancouver Aquarium operates an aquarium. The private company is based in Vancouver, Canada. Vancouver Aquarium was acquired by Herschend Family Entertainment Corp. from Ocean Wise Conservation Association on April 15, 2021. The Canadian company was founded in 1951.
1
| Subsidiary | Miscellaneous Commercial Services | 1 |
Five Corners Capital, Inc.
Five Corners Capital, Inc. Investment ManagersFinance Five Corners Capital Inc (Five Corners Capital) is a venture capital firm founded in 2013 by Kenneth Galbraith and Gary Bridger. The firm is headquartered in British Columbia, Canada.
1
| Private Company | Investment Managers | 1 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ken Galbraith via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal Corporate Officer/Principal | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Centocor, Inc.
Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal | |
JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | Medical Specialties | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
QUEBECOR INC. | Cable/Satellite TV | Director/Board Member General Counsel | |
Corixa Corp.
Corixa Corp. BiotechnologyHealth Technology Corixa Corp. operates as a biopharmaceutical company. It develops and manufactures oncology and immunology products. The firm offers vaccines, immunotherapeutic, monoclonal antibody-based therapeutics, adjuvant and antigen delivery systems, toxin-conjugated, and antigen-specific diagnostic products. The company was founded by Steven H. Gillis and Mark McDade in 1994 and is headquartered in Hamilton, MT. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
PORTOLA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
CELATOR PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal Director/Board Member | |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto. | Investment Managers | Private Equity Investor Private Equity Investor | |
Stanford University | College/University | Masters Business Admin Doctorate Degree | |
University of Oxford | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Founder Chief Tech/Sci/R&D Officer Human Resources Officer | |
University of Cambridge | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
Solect Technology Group, Inc.
Solect Technology Group, Inc. Packaged SoftwareTechnology Services Part of Amdocs Ltd., Solect Technology Group, Inc. provides Internet billing and customer care software. The private company is based in Toronto, Canada. Solect Technology Group was acquired by Amdocs Ltd. on April 06, 2000 for $1,058.99 million. The Canadian company was founded by Paul J. Atkinson, Kevin Kimsa. | Packaged Software | Corporate Officer/Principal Founder | |
McGill University | College/University | Doctorate Degree Graduate Degree Corporate Officer/Principal | |
ALLON THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree | |
Queen's University of Belfast | College/University | Masters Business Admin Masters Business Admin | |
Indiana University | College/University | Doctorate Degree Doctorate Degree Graduate Degree Masters Business Admin | |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Princeton University | College/University | Doctorate Degree Undergraduate Degree | |
Simon Fraser University | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
University of Toronto | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
The University of Waterloo | College/University | Director/Board Member Undergraduate Degree | |
University of Western Ontario | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
University of Montréal | College/University | Graduate Degree Graduate Degree Graduate Degree | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member Director/Board Member | |
London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
University College London | College/University | Undergraduate Degree Undergraduate Degree | |
NDI Capital, Inc.
NDI Capital, Inc. Investment ManagersFinance NDI Capital, Inc (NDI Capital) is a venture capital firm Founded in 2003 and headquartered in Vancouver, British Columbia. | Investment Managers | Founder Chief Executive Officer | |
ALDER BIOPHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
Heptares Therapeutics Ltd.
Heptares Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Heptares Therapeutics Ltd. designs and develops new medicines targeting G protein-coupled receptors. It builts an exciting discovery and development pipeline of novel drug candidates, which have the potential to transform the treatment of serious diseases, including alzheimer's disease, parkinson's disease, schizophrenia, migraine and diabetes. The company was founded by Richard Henderson, Fiona Hamilton Marshall, Ludwig Michael Steinmetz, Christopher G. Tate and Malcolm Weir in 2007 and is headquartered in Welwyn Garden City, the United Kingdom. | Pharmaceuticals: Major | Founder Director/Board Member | |
Québec Bar Assoication
Québec Bar Assoication Financial ConglomeratesFinance The Québec Bar Association is a professional organization that oversees the practice of over 29,000 lawyers in all areas of law. The organization is based in Montréal, Canada. and has subsidiaries in Canada. The mission of the association is to ensure the protection of the public, contribute to accessible and quality justice, and defend the rule of law. | Financial Conglomerates | Corporate Officer/Principal Corporate Officer/Principal | |
British Columbia Bar Association
British Columbia Bar Association Miscellaneous Commercial ServicesCommercial Services British Columbia Bar Association Operates as a law firm association to provide legal services. The company is headquartered in Vancouver, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Bird Rock Bio, Inc.
Bird Rock Bio, Inc. BiotechnologyHealth Technology Bird Rock Bio, Inc. develops protein therapeutics. It focuses on the discovery and development of novel antibodies with upsized potential that represent to antibody therapeutics. The company was founded by Richard J. Ulevitch, Phyllis Ellen Whiteley and Katherine S. Bowdish in 2007 and is headquartered in La Jolla, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
FUSN PHAR | Pharmaceuticals: Major | Chairman Director/Board Member | |
NERVGEN PHARMA CORP. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Anaveon AG
Anaveon AG BiotechnologyHealth Technology Anaveon AG engages in the development of immune therapies against cancer. Its compounds promote effector T-cell functions to enhance a patient?s immune system to respond to tumors. The company was founded on December 11, 2017 by Onur Boyman and Andreas Katopodis and is headquartered in Bottmingen, Switzerland. | Biotechnology | Chairman Director/Board Member | |
Resolution Therapeutics Ltd.
Resolution Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Resolution Therapeutics Ltd. operates as a macrophage cell therapy company. The company was founded on December 14, 2017 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Purespring Therapeutics Ltd.
Purespring Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Purespring Therapeutics Ltd. provides biotechnological research and experimental development services. The company was founded on April 1, 2020 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Chairman Director/Board Member |
Statistiques
Internationale
Etats-Unis | 24 |
Canada | 19 |
Royaume-Uni | 9 |
Suisse | 2 |
Sectorielle
Health Technology | 24 |
Consumer Services | 18 |
Commercial Services | 5 |
Finance | 5 |
Process Industries | 2 |
Opérationnelle
Director/Board Member | 499 |
Corporate Officer/Principal | 212 |
Independent Dir/Board Member | 130 |
Chairman | 87 |
Undergraduate Degree | 73 |
Relations les plus connectées
Insiders | |
---|---|
Michael Steinmetz | 35 |
Arnold Lewis Oronsky | 35 |
Martin Murphy | 33 |
Nancy Orr | 31 |
Roel Bulthuis | 29 |
Michael Hayden | 27 |
Arthur Rosenthal | 26 |
Stuart J. M. Collinson | 25 |
David Jeans | 24 |
Pierre Laurin | 23 |
Susan Mahony | 21 |
Eran Nadav | 21 |
Lota Zoth | 20 |
Troy Cox | 19 |
Jim J. Miller | 19 |
- Bourse
- Insiders
- Ken Galbraith
- Connexions Sociétés